Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome. - Wikidata - awgldk - TriplyDB

Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.

Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.

http://www.wikidata.org/entity/Q33872368

about

Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up.Childhood acromegaly due to X-linked acrogigantism: long term follow-up.The genetic background of acromegaly.Acromegaly: clinical features at diagnosis.Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.

P2860

Q28394993-20A37B17-EB08-4D24-A4DB-71E5D16FE60C Q30276702-5E8DB12F-8F6F-439E-8391-ACE55DB03874 Q36911483-7136B312-FE60-4094-8D48-1CCB56ABBF68 Q37222927-155B32FA-D9D4-4313-A691-CBE967BB3301 Q37593900-D9D33E28-6072-4A3D-8673-1D515D59369E Q37678059-24788E42-AA6D-4065-B936-A3590AB83B5B Q38998304-4BBAB2C8-412D-4EE4-9F29-049E497F3D2B Q47773067-6B9A9CE0-3245-40FF-91A8-0229A8A97AEB

P2860

Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.

http://www.wikidata.org/entity/Q33872368

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Aggressive tumor growth and cl ...... inked acro-gigantism syndrome.

@ast

Aggressive tumor growth and cl ...... inked acro-gigantism syndrome.

@en

type

label

Aggressive tumor growth and cl ...... inked acro-gigantism syndrome.

@ast

Aggressive tumor growth and cl ...... inked acro-gigantism syndrome.

@en

prefLabel

Aggressive tumor growth and cl ...... inked acro-gigantism syndrome.

@ast

Aggressive tumor growth and cl ...... inked acro-gigantism syndrome.

@en

P1433

Q33872368-DF37E344-899A-4B36-A056-92B2ADFAA45E

P1476

Q33872368-5A3764F1-A855-4119-91E8-10196206150E

P2093

Q33872368-05DAB04D-62E6-4DF6-99A1-A37EBF788C74

Q33872368-206F9194-686C-4833-BCC5-0677C0F488D7

Q33872368-22DF2B29-884C-4733-80A2-238047897218

Q33872368-2D5BBF7D-5345-412F-8BD3-89D14794C01C

Q33872368-512BBF61-CD6A-4EAF-9DE9-497F75574508

Q33872368-5482FA44-82B9-4493-8224-E8D61C3E538A

Q33872368-7038F549-73EE-45E1-B8EB-DC5510105D8D

Q33872368-81D3C1BB-06CB-47A9-8A7D-B50BDA90A044

Q33872368-B4F4666A-5F30-424C-ADDA-E236258535C4

Q33872368-B5283846-541C-495A-8D94-0F4213A2310C

P2860

Q33872368-1064B035-6687-42BE-AA78-2DED9F276A80

Q33872368-12655393-4518-4809-AB38-AC0D6E016756

Q33872368-1E481058-B5C0-4E5C-8AE3-462DA264CD06

Q33872368-24475015-CDF1-4B60-8991-27BD83A48F5A

Q33872368-489D5C8F-C6F1-4B1F-9F6C-2B86F725DB1D

Q33872368-497C7845-6477-4C86-BE6F-8D77550CA22D

Q33872368-5096BE5E-D21B-49E6-B9A2-BE83759402FF

Q33872368-59E3EC4F-D058-46B5-AD78-29492E765B98

Q33872368-77CCE2E5-9FFE-4095-BE9F-489029CC73C8

Q33872368-7F884627-6E5F-435D-9DB1-702AEF001D1C

P2888

Q33872368-65117811-7915-446B-81BC-52ADD8E1AA0B

P304

Q33872368-868F1405-8679-478E-9091-03B2E99F483E

P31

Q33872368-1CEC800F-1E8F-49E4-915D-FAA8D0A68AA0

P356

Q33872368-D1E90FD0-355A-4F53-987D-CB3E08684737

P433

Q33872368-C1245866-0DD0-41AE-8D2D-D95541C1DEFA

P478

Q33872368-F3565662-C3AE-405C-BE98-50631C9793BD

P50

Q33872368-9C45ED27-6796-4910-AE28-607FBB7B25E6

Q33872368-A9A23558-A591-4C50-9331-C5FD95F49A26

Q33872368-F6273D0F-1A1D-4404-8F4E-00003E6981BD

Q33872368-FF0C8802-5A37-454F-BDC0-8F4DE9B9F9C2

P577

Q33872368-8196F071-4348-4F33-B2ED-E05664E98EFA

P5875

Q33872368-8243E092-F4D8-4D4E-8975-065C8CDB70E3

P698

Q33872368-1F3186FD-A8BC-4D89-BF63-3333753C37C6

P932

Q33872368-C92E739A-4881-47ED-B869-6988A1C41874

P356

S12020-015-0804-6

P1433

P1476

Aggressive tumor growth and cl ...... inked acro-gigantism syndrome.

@en

P2093

Albert Beckers

http://www.w3.org/2001/XMLSchema#string

Armindo Jreige Júnior

http://www.w3.org/2001/XMLSchema#string

Bo Yuan

http://www.w3.org/2001/XMLSchema#string

Chiara Villa

http://www.w3.org/2001/XMLSchema#string

Constantine A Stratakis

http://www.w3.org/2001/XMLSchema#string

Florêncio Figueiredo Cavalcante Neto

http://www.w3.org/2001/XMLSchema#string

James R Lupski

http://www.w3.org/2001/XMLSchema#string

Juliano Coelho Oliveira Zakir

http://www.w3.org/2001/XMLSchema#string

Leonor Palmeira

http://www.w3.org/2001/XMLSchema#string

Luciana A Naves

http://www.w3.org/2001/XMLSchema#string

P2860

Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.

X-linked acrogigantism syndrome: clinical profile and therapeutic responses

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.

AIP mutation in pituitary adenomas in the 18th century and today.

Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy

Clinical features and treatment of pediatric somatotropinoma: case study of an aggressive tumor due to a new AIP mutation and extensive literature review.

Investigation and management of tall stature.

Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient.

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

P2888

s12020-015-0804-6

P304

236-244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12020-015-0804-6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Giampaolo Trivellin

Natalia S. Pellegata

Gustavo Barcelos Barra

P577

2015-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284729127

http://www.w3.org/2001/XMLSchema#string

P698

26607152

http://www.w3.org/2001/XMLSchema#string

P932

5497487

http://www.w3.org/2001/XMLSchema#string